I recently held a conversation with a former hedge fund analyst where we discussed his time in Wall Street including the twelve years he had to spend in three hedge funds, including Paulson & Co. He mentioned that my colorful writings caught his attention. The article was titled ‘An Ode To Those Who Wander.’ And in this article will cover his experience at Wall Street, though briefly.
This guy graduated from Penn State, his spirit of hustling and networking skills landed him an internship on a credit trading firm, Merrill Lynch, in New York City where he stayed there for the next three years. After leaving Merrill Lynch, he went to Longacre, which was then a $3 billion hedge fund. This is where he met with Sahm Adrangi, the founder of hedge fund firm called Kerrisdale Capital.
Recently, Sahm Adrangi published an article titled: Northern Dynasty (NYSEMKT: NAK) ‘The Pebble Deposit Isn’t Commercial Viable.’ This piece was well received by the market. Sahm Adrangi’s article presented us with an opportunity to get back our position in NAK. After Longacre, he joined Paulson & Co. Where he worked as credit PM for three years.
Due to economic constraints, he decided to leave Wall Street in 2015. But the love of investing never left him. His sizeable income comes from securities he made in Wall Street. I was curious as to why he agreed we meet. He said that he loved my ‘high caliber’ my passion for research. It turned out that he too adores conducting extensive research.
What he said is not an accident. I make sure that my articles are action-packed and with great tips my readers can’t get anywhere else. We started talking about markets; he mentioned that he agreed 100 percent with my thesis on GNC markets.
About Sahm Adrangi
He is the founder and Chief Investment Officer of Kerrisdale Capital Management. He started the firm in 2009, and since then, he has been in the forefront in the day-to-day running of the company. The company currently manages capital worth over $150 million. Samh Adrangi is known for his extensive yet short research. He first came to limelight when he exposed corrupt Chinese companies in 2010 and 2011. Besides working on stocks, Sahm also concentrates on biotechnology sector.